Project Notice |
|
| PNR | 16793 |
| Project Name | Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome |
| Project Detail | The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five resistance interacting pathways. Given the frequent Tamoxifen treatment failure, resistance prevention and reversal is an urgent clinical problem t… |
| Funded By | European union |
| Sector | Health and Medical |
| Country | Netherlands The , Western Europe |
| Project Value | EUR 2,797,697 |
Contact Information |
|
| Company Name | UNIVERSITEIT VAN AMSTERDAM |
| Address | SPUI 21 1012WX AMSTERDAM Netherlands |
| Web Site | http://cordis.europa.eu/project/rcn/193941_en.html |
